Entasis Therapeutics United States of America (USA)

Research

Date range: 1 December 2020 - 30 November 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Entasis Therapeutics published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Entasis Therapeutics
Count Share
1 0.58

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.58

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.00 0.00

Compare Entasis Therapeutics with other institutions

Collaboration

Date range: 1 December 2020 - 30 November 2021

International vs. domestic collaboration by Share

  • 44.52% Domestic
  • 55.48% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Entasis Therapeutics by Share (4 total)

  1. Entasis Therapeutics and University of Florida (UF) (0.65)
    Entasis Therapeutics0.58
    University of Florida (UF)0.08
  2. Entasis Therapeutics and Colorado State University (0.65)
    Entasis Therapeutics0.58
    Colorado State University0.08
  3. Entasis Therapeutics and Johnson & Johnson (0.60)
    Entasis Therapeutics0.58
    Johnson & Johnson0.02
  4. Entasis Therapeutics and Pfizer Inc. (0.60)
    Entasis Therapeutics0.58
    Pfizer Inc.0.02

Top 10 international collaborators with Entasis Therapeutics by Share (5 total)

  1. Entasis Therapeutics and UCB S.A. (0.65)
    Entasis Therapeutics0.58
    UCB S.A.0.08
  2. Entasis Therapeutics and Novartis International AG (0.63)
    Entasis Therapeutics0.58
    Novartis International AG0.06
  3. Entasis Therapeutics and Alkermes plc (0.62)
    Entasis Therapeutics0.58
    Alkermes plc0.04
  4. Entasis Therapeutics and Takeda Pharmaceutical Company Limited (0.62)
    Entasis Therapeutics0.58
    Takeda Pharmaceutical Company Limited0.04
  5. Entasis Therapeutics and Merck KGaA (0.60)
    Entasis Therapeutics0.58
    Merck KGaA0.02